Dutch EU presidency to raise controversial health funding issues
This article was originally published in Clinica
Are the principles of the EU's internal market compatible with those of subsidiarity when it comes to the organisation and funding of healthcare services? That is an issue the Dutch government wishes to investigate during its six-month presidency of the EU Council.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.